• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Walgreens Study: Pill Reminder, Activity Tracking Features Improves Medication Adherance

by HITC Staff 09/13/2016 Leave a Comment

walgreens-digital-health

Walgreens mobile pill reminder feature and its activity tracking digital health solutions has improved medication adherence among pharmacy patients, according to two recent company studies. Recent Walgreens research has shown that consumers over 50 years of age who track activities through its Balance® Rewards for healthy choices (BRhc) program, which awards loyalty points for healthy behaviors and activities, are more adherent to their medication therapies. A separate Walgreens study found that the pill reminder feature within the Walgreens mobile app is also demonstrating better optimal adherence[1] among users. 

Balance Rewards for healthy choices and patients over 50 Study

The Walgreens retrospective cohort study examined patients who filled an antihypertensive, oral antidiabetic or antihyperlipidemic medication among those 50 years old or greater, between March and October 2014. The findings concluded that tracking physical activity four or more times per week were 11.2 percent higher for antihypertensives, 5.1 percent higher for oral antidiabetics and 4.5 percent higher for antihyperlipidemics. 

[2] In addition, tracking blood pressure twice or more per week or tracking blood glucose once or more per week was associated with significantly better optimal adherence: 6.8 percent higher for patients taking antihypertensives and 12.3 percent higher for oral antidiabetics.

Mobile Pill Reminder Research Findings

For the mobile pill reminder feature, the Walgreens study took a group comprised of patients who used the pill reminder and had oral antidiabetic, antihypertensive or antihyperlipidemic medications between an index period of January 2014 and September 2014 and compared to a control group comprised of those who did not use the pill reminder.

The research found that utilization of the Walgreens mobile app pill reminder was 12.3 percent higher for oral antidiabetics, 11.3 percent higher for antihypertensives and 9.1 percent higher for antihyperlipidemics.

References

[1]  Defined as having PDC (Proportion of Days Covered) >= 80%.  PDC is a PQA (Pharmacy Quality Alliance) recommended metric for estimating medication adherence and PQA selected PDC >=80% to be considered as highly-adherent.
[2] Akinbosoye O, Taylor D, Jiang J, Taitel M, Orr G. The Relationship Between Digital Health Program Activity Tracking and Medication Adherence Among Members Age 50+ years. JMCP APRIL 2016 Vol. 22, No.4-a S44
[3] Akinbosoye O, Jiang J, Taitel M, Orr G ‘The Association between Use of a Community Pharmacy’s Mobile Pill Reminder App and Medication Adherence’ Presented at the Society of Behavioral Medicine 37th Annual Meeting, March 30- April 2, 2016, Washington DC.

Tagged With: Medication Adherance, Walgreens

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |